Structural failures at MetroLoft, David Werner’s Midtown conversion could recast the value of unused air rights.

Both Pfizer and Gilead Sciences just flashed the same ominous technical warning while trading below analyst fair value.

Pfizer (PFE) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the facts that could shape the stock's performance in the near term. Shares of this ...

Buffett’s casino comments raise an uncomfortable truth. Is biotechnology an investment, or is it more of a gambling casino?

ORIC Pharmaceuticals advances rinzimetostat into the global Phase 3 Himalayas-1 trial for mCRPC, with full global rights.

U.S. drugmaker Pfizer has temporarily discontinued Premarin vaginal cream in India, shrinking estrogen therapy options for ...

Baker Brothers’ Q1 2026 13F portfolio rose to $17.42B, with top five holdings—Incyte, BeOne Medicines, Insmed, Madrigal ...

The companies aim to enable simplified dosing and delivery methods for patients receiving treatment for MPNs.

Singapore state investor sees opportunity in undervalued Chinese equities, life sciences and AI despite recent market headwinds ...

When a regular paycheck disappears in retirement, the stakes of every investment decision skyrocket. These five high-yield ...

Law firms are investing millions in AI, but in-house counsel across Asia say the promised efficiencies have yet to translate ...

July 16, 2026 expert reaction to new JCVI recommendations for the MenB vaccine in adolescents . Scientists comment on new JCVI recommendations for the MenB vaccine. Prof Hannah Ch ...